Showing results (841-850 of 2,363) with videos related to
Sort By:
Pageof 237
Future Medicinal Chemistry|December 23, 2015
The Janus-faced nature of IDO1 in infectious diseases: challenges and therapeutic opportunitiesFrancesco Antonio Greco, Alice Coletti, Emidio Camaioni, et al.Future Medicinal Chemistry|December 17, 2015
ACAT1/SOAT1 as a therapeutic target for Alzheimer's diseaseYohei Shibuya, Catherine Cy Chang, Ta-Yuan ChangFuture Medicinal Chemistry|December 15, 2015
The design of multitarget ligands for chronic and neuropathic painSzabolcs Dvoracsko, Azzurra Stefanucci, Ettore Novellino, et al.Future Medicinal Chemistry|October 28, 2015
The anti-tuberculosis agents under development and the challenges aheadDeepak Kumar, Beena Negi, Diwan S RawatFuture Medicinal Chemistry|October 30, 2015
Protein-protein interactions as drug targetsMalgorzata Skwarczynska, Christian OttmannFuture Medicinal Chemistry|October 30, 2015
Rational approach to an antiprion compound with a multiple mechanism of actionMaria Laura Bolognesi, Salvatore Bongarzone, Suzana Aulic, et al.Future Medicinal Chemistry|October 15, 2015
Therapeutic oligonucleotides with polyethylene glycol modificationsJohannes WinklerFuture Medicinal Chemistry|January 26, 2016
Inhibition of bacterial and fungal pathogens by the orphaned drug auranofinBeth Burgwyn Fuchs, Rajmohan RajaMuthiah, Ana Carolina Remondi Souza, et al.Future Medicinal Chemistry|January 30, 2016
SAR studies on FXR modulators led to the discovery of the first combined FXR antagonistic/TGR5 agonistic compoundChristina Lamers, Daniel Merk, Matthias Gabler, et al.Future Medicinal Chemistry|March 3, 2016
Targeting the JAK-STAT pathway in the treatment of 'Th2-high' severe asthmaKara ValePageof 237